Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2014

View Archived Issues

Phase II results show vismodegib is well tolerated in patients with mPDA

Kissei gains approval for Savene in Japan

XBiotech launches phase II study in rare disorder pyoderma gangrenosum

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance awards grant to ADA

Oryzon cleared to begin phase I/IIa trial of ORY-1001 in the U.K.

Researchers in the U.S. prepare new GWT1 inhibitors for fungal infections

Novel ALK/c-Met inhibitors disclosed by Concert Pharmaceuticals

Novel biomarkers for breast cancer prognosis identified and evaluated

Dart NeuroScience discloses novel PDE1B inhibitors

Inhibition of immune cell priming to ameliorate autoimmune inflammatory diseases

Scientists at Merck & Co. patent new SYK inhibitors

Development of a novel class of tau ligands for medical imaging of AD

Aniona prepares novel GABA(A) modulators

Researchers at Bristol-Myers Squibb design new monoclonal antibodies

NovoEight obtains Japanese approval

Giotrif approved in Japan for patients with NSCLC and EGFR mutation

FDA extends review of Trimel's NDA for CompleoTRT

Karyopharm targets PAK-4 in pancreatic cancer

Sovaldi approved in Europe for treatment of chronic HCV infection

Shire sells Dermagraft assets to Organogenesis

Kyowa Hakko Kirin obtains approval for new formulation of antiepileptic agent in Japan

Ariad's Iclusig now commercially available in U.S.

Acerta Pharma launches phase I trial of novel BTK inhibitor in CLL

Mitsubishi Tanabe files for use of Telavic in additional indication in Japan

Biocon launches biosimilar version of Herceptin in India

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...